TriMas Logo
NASDAQ: TRS $27.37
+0.00 (0.00%)

pdfDownload Press Release 

BLOOMFIELD HILLS, Michigan, May 6, 2024 – TriMas (NASDAQ: TRS) today announced that Jim Kepler has been appointed to Vice President and General Manager of TriMas’ Life Sciences group, effective April 29, 2024. In this position, Jim will report directly to Fabio Salik, President, TriMas Packaging.

As Vice President and General Manager of TriMas' Life Sciences group, Jim will assume full P&L responsibility for the division. Leading the Life Sciences team, Jim will focus on driving profitable sales growth, operational excellence, M&A activities and new product innovations.

Jim became part of TriMas in 2022 through its acquisition of Intertech. Over his 25-year tenure, he has steered Intertech's growth into Colorado's largest injection molding manufacturer, particularly prominent in the medical device industry. Jim's leadership has been pivotal in achieving this success, emphasizing the development of high-performing teams and the adoption of cutting-edge technologies, such as highly automated quality compliance and manufacturing systems. In addition to his focus on organizational success, Jim has made substantial investments in developing top talent and educational initiatives. He actively promotes manufacturing awareness in STEM programs within the Denver Public School district and is deeply involved in implementing CareerWise, a nationally recognized apprenticeship program.

About TriMas
TriMas manufactures a diverse set of products primarily for the consumer products, aerospace and industrial markets through its TriMas Packaging, TriMas Aerospace and Specialty Products groups. Our approximately 3,400 dedicated employees in 13 countries provide customers with a wide range of innovative and quality product solutions through our market-leading businesses. Our TriMas family of businesses has strong brand names in the markets served, and operates under a common set of values and strategic priorities under the TriMas Business Model. TriMas is publicly traded on the NASDAQ under the ticker symbol “TRS,” and is headquartered in Bloomfield Hills, Michigan. For more information, please visit

Sherry Lauderback
VP, Investor Relations & Communications
(248) 631-5506
This email address is being protected from spambots. You need JavaScript enabled to view it.